Procarta Biosystems Seed
1 known investors
Procarta Biosystems develops oligonucleotide-based antimicrobial drugs to treat serious bacterial infections, including strains resistant to existing antimicrobials. The company is a drug discovery and development biotech focused on combating antimicrobial resistance (AMR).
Investors · 1
Frequently asked questions
- What does Procarta Biosystems Seed do?
- Procarta Biosystems develops oligonucleotide-based antimicrobial drugs to treat serious bacterial infections, including strains resistant to existing antimicrobials. The company is a drug discovery and development biotech focused on combating antimicrobial resistance (AMR).
- Who are Procarta Biosystems Seed's investors?
- Procarta Biosystems Seed's investors include Future Planet Capital.